FindTrial
Sign In

effect of perineural dexamethasone and intravenous dexamethasone with 0.5 percent ropivacaine in supraclavicular brachial plexus block in upper limb surgeries.

A randomized comparative study of effect of perineural dexamethasone and intravenous dexamethasone with 0.5 percent ropivacaine in supraclavicular brachial plexus block in upper limb surgeries. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075258
Enrollment
72
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S560- Injury of flexor muscle, fascia and tendon of thumb at forearm level Health Condition 2: S578- Crushing injury of forearm Health Condition 3: S530- Subluxation and dislocation of radial head Health Condition 4: S520- Fracture of upper end of ulna Health Condition 5: S521- Fracture of upper end of radius

Interventions

Intervention1: perineural dexamethsone: after randomization, one group will receive Inj. Ropivacaine 0.5% 25ml [perineural] with dexamethasone 8mg [perineural] Control Intervention1: intravenous dex

Sponsors

Pacific Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients aged between 18-65 years. 2. Patient weight between 50 kg -80 kg. 3. American society of Anesthesiologists (ASA) Physical Status I and II. 4. Elective upper limb surgery under supraclavicular brachial plexus block.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To study onset and duration of sensory &motor block Timepoint: 8 months—

Secondary

MeasureTime frame
To study 1.Duration of analgesia 2.Rescue analgesia dose &time 3.Complication if anyTimepoint: 8 months—

Countries

India

Contacts

Public ContactDr Khodifad Jatin

Pacific Medical And Hospital

jhkhodifad9@gmail.com9825047338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026